Statement: Coronavirus 2019-nCoV

Statement: Coronavirus 2019-nCoV

The rendering is licensed under: CC BY-SA 4.0. The Phyre2 model is courtesy of Innophore ( and the Phyre2 web portal ( Phyre2 citation: Lawrence A Kelley, Stefans Mezulis, Christopher M Yates, Mark N Wass, Michael J E Sternberg: The Phyre2 web portal for protein modeling, prediction and analysis. In: Nature Protocols. 10, 2015, p. 845, doi:10.1038/nprot.2015.053. Innophore citation: doi:10.6084/m9.figshare.11752752.

In Wuhan City, Hubei Province, China, cases with the new coronavirus temporary named 2019-nCoV (beta-coronavirus) are occurring causing respiratory infections. This new virus is very similar to SARS and MERS being responsible for respiratory infections in the past. Most clinical findings with 2019-nCoV show a mild illness, but also severe cases with a small number of fatalities are reported. The WHO has published a guidance for the clinical management (interims guidance of clinical management of suspected cases). It is likely that the outbreak will persist and more infections will be reported during the next days and weeks due to the virus spread when infected persons are travelling to other countries. 

2019-nCoV belongs to the group of enveloped viruses and is consequently covered by an activity claim against all enveloped viruses in a quantitative suspension test according to EN 14476, where the reference test virus is vaccinia virus.
For the time being, activity tests of chemical disinfectants against the outbreak strain are not possible, but we can offer to use bovine coronavirus as surrogate test virus of 2019-nCoV.

Recommendation for hygienic measures  are recently published by the Robert Koch-Institute in Berlin ( The main and most important infection prevention measurement for the public is frequent hand wash and disinfection (

There is no reason for panic. The Chinese and other governments are taking very restrictive measures, much more than with any influenza or the MERS and SARS outbreaks of the past years.